MAPT and tauopathy: FBA studies showed a specific pattern of bundle atrophy following axonal degeneration by quantifying fiber density and fiber bundle cross-section in 4R tauopathy and have been suggested as a better tool than DTI to assess in vivo, disease-specific, WM changes correlating with neuropathology findings associated with 4R tau spread and clinical symptoms, which could help monitor for disease progression.